Marie-Claude Potier
Biographic Data
| ID | 7970599 |
|---|---|
| NAME | Marie-Claude Potier |
| GIVEN NAMES | Marie-Claude |
| FAMILY NAME | Potier |
| SIGNATURE | POTIER M |
| AFFILIATIONS | Centre National de la Recherche Scientifique |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Factors influencing patient decision-making on a multimodal precision medicine algorithm for depression
While patients are open to the use of a multimodal precision medicine algorithm for MDD, they emphasised the need for individualised, transparent communication and emotional support. The results highlight the importance of patient-centred communication strategies and guidelines for the ethical implementation of precision psychiatry
Attitudes towards a multimodal precision medicine algorithm for predicting treatment response in depression
Overall, participants indicated a large degree of acceptance towards the application of a multimodal precision medicine algorithm. Although limited by the hypothetical nature of the decision scenario, this study provides valuable perspectives from different stakeholders. Future research should move beyond attitudes and address further implementation hurdles that need to be overcome for the successful implementation of novel precision psychiatry a…
An integrated precision medicine approach in major depressive disorder
Major depressive disorder (MDD) is the most common psychiatric disease worldwide with a huge socio-economic impact. Pharmacotherapy represents the most common option among the first-line treatment choice; however, only about one third of patients respond to the first trial and about 30% are classified as treatment-resistant depression (TRD). TRD is associated with specific clinical features and genetic/gene expression signatures. To date, single …
No prominent works on this page.
An integrated precision medicine approach in major depressive disorder
Major depressive disorder (MDD) is the most common psychiatric disease worldwide with a huge socio-economic impact. Pharmacotherapy represents the most common option among the first-line treatment choice; however, only about one third of patients respond to the first trial and about 30% are classified as treatment-resistant depression (TRD). TRD is associated with specific clinical features and genetic/gene expression signatures. To date, single …
Factors influencing patient decision-making on a multimodal precision medicine algorithm for depression
While patients are open to the use of a multimodal precision medicine algorithm for MDD, they emphasised the need for individualised, transparent communication and emotional support. The results highlight the importance of patient-centred communication strategies and guidelines for the ethical implementation of precision psychiatry
Attitudes towards a multimodal precision medicine algorithm for predicting treatment response in depression
Overall, participants indicated a large degree of acceptance towards the application of a multimodal precision medicine algorithm. Although limited by the hypothetical nature of the decision scenario, this study provides valuable perspectives from different stakeholders. Future research should move beyond attitudes and address further implementation hurdles that need to be overcome for the successful implementation of novel precision psychiatry a…
Precision medicine (3 works) · Digital Mental Health Interventions (2 works) · MEDLINE (2 works) · Mental Health Treatment and Access (2 works) · Personalized medicine (2 works) · Treatment of Major Depression (2 works) · Accuracy and precision (1 work) · Alternative medicine (1 work) · Bioinformatics (1 work) · Biology (1 work)